News and Announcements
Proteomics Investor Presentation August 2015
- Published August 20, 2015 11:50AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
20th August 2015, ASX Announcement
About Proteomics International Laboratories Ltd
Proteomics International Laboratories Ltd (PILL) (ASX: PIQ) is an emerging life science company focused on the area of proteomics, the industrial scale study of the structure and function of proteins. Proteomics is a key component of the biotechnology and life sciences industries and plays a vital role in understanding disease and biological systems, and the Company is recognised as a global leader in the field.
Its business model is based on its proprietary technology platform which operates across three synergistic business units in massive growth markets: analytical services, diagnostics and therapeutic drug discovery. The Company listed on the ASX in April 2015 after raising $3m in an IPO and the funds raised will be used to expand each business unit.
If you would like to read their Investor Presentation, please click here.